- In July 2021, Heron Therapeutics Inc., a U.S.-based company, launched ZYNRELEF, an extended-release product designed to provide postsurgical pain relief for up to 72 hours after procedures such as bunionectomy, inguinal hernia repair, or total knee replacement, targeting soft tissue and periarticular applications
- In June 2021, Bayer bolstered its presence in the Indian market by launching its Consumer Health division, aiming to enhance access to over-the-counter (OTC) health products. This move supports Bayer's strategy to expand its consumer health portfolio in key emerging markets such as India
- In January 2021, Eli Lilly & Co. finalized a licensing agreement with Japan's Asahi Kasei Pharma, allowing the U.S. based company to develop and commercialize Asahi Kasei's innovative therapies. The partnership is focused on advancing treatments in key therapeutic areas, benefiting patients globally
- In January 2021, Pfizer formed a partnership with Premier, a U.S.-based healthcare improvement company, to provide five essential medications to healthcare practitioners, aimed at addressing both immediate and long-term medication needs for various patient care interventions
- In May 2020, California-based Assertio Therapeutics, Inc. merged with Pennsylvania-based Zyla Life Sciences, forming an expanding commercial pharmaceutical company focused on neurology, inflammation, and pain management products
